Equities
Health CareHealth Care Providers
  • Price (USD)16.30
  • Today's Change0.50 / 3.16%
  • Shares traded26.25m
  • 1 Year change-72.46%
  • Beta2.5532
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

  • Revenue in USD (TTM)2.21bn
  • Net income in USD133.79m
  • Incorporated2021
  • Employees1.64k
  • Location
    Hims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
  • Phone+1 (415) 851-0195
  • Fax+1 (302) 655-5049
  • Websitehttps://www.forhims.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HIMS:NYQ since
announced
Transaction
value
Zava Global GmbhDeal completed03 Jun 202503 Jun 2025Deal completed-71.29%--
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Surgery Partners Inc3.29bn-171.40m2.00bn15.00k--1.1511.540.6081-1.36-1.3625.9413.410.424827.715.86219,206.700.3010.97260.42971.3626.5726.230.70862.461.722.290.5007--13.5211.20-1,312.61--4.20--
Select Medical Holdings Corp4.06bn-34.63m2.03bn30.00k--1.2012.390.50-0.25920.920532.7113.640.5927--4.30135,206.500.20213.000.25643.8511.9212.700.3414.19--2.250.467332.737.48-0.998210.99-15.137.17--
Addus Homecare Corporation1.35bn85.65m2.10bn6.17k24.372.0020.801.564.674.6773.4356.811.05--11.68218,426.006.655.397.586.2532.6631.716.365.43--12.660.12550.009.0612.2217.7323.315.54--
CorVel Corp941.49m105.73m2.52bn5.08k24.106.7018.392.672.042.0418.187.351.59--9.04185,515.9017.8716.1629.5226.6624.2222.6011.239.71----0.000.0012.618.6224.8014.972.02--
GeneDx Holdings Corp402.19m2.08m2.61bn1.00k1,455.688.9179.506.480.06190.061914.0510.120.89111.448.11402,190.000.4615-62.350.5647-78.9069.6520.780.5179-111.422.594.050.153--50.799.2670.25---18.70--
National Healthcare Corp1.50bn101.25m2.63bn14.96k26.182.5017.781.756.486.4896.0367.870.9574117.5911.49100,295.306.605.457.976.6138.5539.296.896.541.72--0.064646.4314.535.5852.598.360.8933.30
Lifestance Health Group Inc1.37bn-9.12m2.73bn8.00k--1.8358.342.00-0.0239-0.02393.543.840.6425--9.80133,839.30-0.4283-8.96-0.4785-9.73-----0.6667-19.11--0.56840.1589--18.5042.5569.16--8.54--
Privia Health Group Inc2.04bn18.17m2.75bn1.14k157.543.8881.911.350.14210.142115.995.771.64--4.501,791,727.001.96-3.813.68-6.2710.179.481.20-2.05----0.00--4.7417.17-37.6711.78----
Concentra Group Holdings Parent Inc2.09bn151.68m3.02bn8.76k11.567.8313.081.442.042.0420.683.010.7848--8.17238,567.905.99--6.79--28.36--7.63----3.070.7972--3.38---7.45------
Hims & Hers Health Inc2.21bn133.79m3.71bn1.64k30.316.3821.041.680.53780.53788.852.551.567.1296.331,350,616.009.44-3.9111.99-4.7475.01--6.05-2.351.64--0.6257--69.33--635.28155.96----
Brookdale Senior Living Inc3.22bn-306.65m3.92bn24.48k----49.441.22-1.31-1.3113.82-0.02830.539--53.43131,573.60-5.13-2.05-5.72-2.2926.1422.53-9.52-4.24--0.36251.00--3.64-5.08-6.84--0.958--
Alignment Healthcare Inc3.64bn-20.81m4.04bn1.68k--24.94479.791.11-0.1165-0.116518.100.80944.05--20.282,166,263.00-2.34-24.01-5.10-39.6312.4212.08-0.5784-7.96--0.28360.666--48.2528.9913.50--32.23--
Sotera Health Co1.15bn55.42m4.86bn3.00k88.708.8424.314.230.1930.1934.031.940.36329.326.76383,459.701.75-0.39771.88-0.443355.9855.044.82-1.192.162.470.8028--4.887.17-13.21--25.61--
Radnet Inc1.97bn-12.71m5.38bn8.55k--5.0631.902.73-0.1828-0.182825.5313.740.5676--8.71230,470.300.6171.200.79071.5921.3322.021.091.90--1.320.45490.0013.189.65-8.25-28.3220.46--
Data as of Feb 13 2026. Currency figures normalised to Hims & Hers Health Inc's reporting currency: US Dollar USD

Institutional shareholders

52.42%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 202523.16m10.64%
The Vanguard Group, Inc.as of 31 Dec 202519.19m8.82%
JPMorgan Investment Management, Inc.as of 31 Dec 202515.00m6.89%
Capital Research & Management Co. (World Investors)as of 31 Dec 202514.32m6.58%
Farallon Capital Management LLCas of 30 Sep 202510.75m4.94%
Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 20259.76m4.48%
SSgA Funds Management, Inc.as of 31 Dec 20257.31m3.36%
Geode Capital Management LLCas of 31 Dec 20255.51m2.53%
Renaissance Technologies LLCas of 31 Dec 20254.82m2.21%
UBS Securities LLCas of 31 Dec 20254.26m1.96%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.